NORTHERN TRUST CORP - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,532,489
-17.6%
394,251
+3.5%
0.00%0.0%
Q2 2023$4,285,440
+35.5%
380,928
+38.8%
0.00%0.0%
Q1 2023$3,161,929
-2.9%
274,473
-2.3%
0.00%0.0%
Q4 2022$3,257,195
-3.8%
281,035
+5.4%
0.00%0.0%
Q3 2022$3,386,000
+85.2%
266,581
+0.2%
0.00%
Q2 2022$1,828,000
-26.1%
266,038
+3.7%
0.00%
Q1 2022$2,474,000
-20.3%
256,664
-1.7%
0.00%
-100.0%
Q4 2021$3,106,000
-25.6%
261,235
+1.6%
0.00%0.0%
Q3 2021$4,177,000
-26.5%
257,212
-4.8%
0.00%0.0%
Q2 2021$5,686,000
+108.7%
270,231
+54.0%
0.00%0.0%
Q1 2021$2,724,000
-20.1%
175,445
+8.1%
0.00%0.0%
Q4 2020$3,408,000162,3100.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders